NERV – Minerva Neurosciences, Inc.
Minerva Neurosciences, IncNERV
$1.54Name : Minerva Neurosciences, Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $10,757,963.00
EPSttm : 0.19
Minerva Neurosciences, Inc
$1.54
8.43%$0.1417Float Short %
0.5
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
-0.34
EPS Last/This Y
-2.87
EPS This/Next Y
0.8
Price
1.56
Target Price
5
Analyst Recom
3
Performance Q
-20.71
Relative Volume
0.28
Beta
-0.37
Ticker: NERV
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-04-15 | NERV | 1.475 | N/A | N/A | 0 |
| 2025-04-16 | NERV | 1.55 | N/A | N/A | 0 |
| 2025-04-17 | NERV | 1.58 | N/A | N/A | 0 |
| 2025-04-18 | NERV | 1.6 | N/A | N/A | 0 |
| 2025-04-21 | NERV | 1.66 | N/A | N/A | 0 |
| 2025-04-22 | NERV | 1.67 | N/A | N/A | 0 |
| 2025-04-23 | NERV | 1.75 | N/A | N/A | 0 |
| 2025-04-24 | NERV | 1.75 | N/A | N/A | 0 |
| 2025-04-25 | NERV | 1.76 | N/A | N/A | N/A |
| 2025-04-28 | NERV | 1.79 | N/A | N/A | N/A |
| 2025-04-29 | NERV | 1.725 | N/A | N/A | 0 |
| 2025-04-30 | NERV | 1.71 | N/A | N/A | 0 |
| 2025-05-01 | NERV | 1.67 | N/A | N/A | 0 |
| 2025-05-02 | NERV | 1.7 | N/A | N/A | 0 |
| 2025-05-05 | NERV | 1.71 | N/A | N/A | 0 |
| 2025-05-06 | NERV | 1.65 | N/A | N/A | 0 |
| 2025-05-07 | NERV | 1.6 | N/A | N/A | 0 |
| 2025-05-08 | NERV | 1.5912 | N/A | N/A | 0 |
| 2025-05-09 | NERV | 1.6247 | N/A | N/A | 0 |
| 2025-05-12 | NERV | 1.6311 | N/A | N/A | 0 |
| 2025-05-13 | NERV | 1.63 | N/A | N/A | 0 |
| 2025-05-14 | NERV | 1.56 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-04-15 | NERV | 1.48 | 5.3 | - | -2.68 |
| 2025-04-16 | NERV | 1.55 | 5.3 | - | -2.68 |
| 2025-04-17 | NERV | 1.60 | 5.3 | - | -2.68 |
| 2025-04-18 | NERV | 1.60 | 5.3 | - | -2.68 |
| 2025-04-21 | NERV | 1.61 | 5.3 | - | -2.68 |
| 2025-04-22 | NERV | 1.71 | 5.3 | - | -2.68 |
| 2025-04-23 | NERV | 1.78 | 5.3 | - | -2.68 |
| 2025-04-24 | NERV | 1.79 | 5.3 | - | -2.68 |
| 2025-04-25 | NERV | 1.76 | 5.3 | - | -2.68 |
| 2025-04-28 | NERV | 1.79 | 5.3 | - | -2.68 |
| 2025-04-29 | NERV | 1.73 | 5.3 | - | -2.68 |
| 2025-04-30 | NERV | 1.67 | 5.3 | - | -2.68 |
| 2025-05-01 | NERV | 1.71 | 5.3 | - | -2.68 |
| 2025-05-02 | NERV | 1.70 | 5.3 | - | -2.68 |
| 2025-05-05 | NERV | 1.71 | 5.3 | - | -2.68 |
| 2025-05-06 | NERV | 1.66 | 5.3 | - | -2.68 |
| 2025-05-07 | NERV | 1.60 | 5.3 | - | -2.68 |
| 2025-05-08 | NERV | 1.60 | 5.3 | - | -2.68 |
| 2025-05-09 | NERV | 1.61 | 5.3 | - | -2.68 |
| 2025-05-12 | NERV | 1.63 | 5.3 | - | -2.68 |
| 2025-05-13 | NERV | 1.63 | 5.3 | - | -2.68 |
| 2025-05-14 | NERV | 1.56 | 5.3 | - | -2.68 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-04-15 | NERV | 0.00 | -1.48 | 0.58 |
| 2025-04-16 | NERV | 0.00 | -1.48 | 0.58 |
| 2025-04-17 | NERV | 0.00 | -1.48 | 0.58 |
| 2025-04-18 | NERV | 0.00 | -1.48 | 0.58 |
| 2025-04-21 | NERV | 0.00 | -0.52 | 0.58 |
| 2025-04-22 | NERV | 0.00 | -0.52 | 0.58 |
| 2025-04-23 | NERV | 0.00 | -0.52 | 0.58 |
| 2025-04-24 | NERV | 0.00 | -0.52 | 0.58 |
| 2025-04-25 | NERV | 0.00 | -0.52 | 0.58 |
| 2025-04-28 | NERV | 0.00 | -0.54 | 0.51 |
| 2025-04-29 | NERV | 0.00 | -0.54 | 0.51 |
| 2025-04-30 | NERV | 0.00 | -0.54 | 0.51 |
| 2025-05-01 | NERV | 0.00 | -0.54 | 0.51 |
| 2025-05-02 | NERV | 0.00 | -0.54 | 0.51 |
| 2025-05-05 | NERV | 0.00 | -0.55 | 0.51 |
| 2025-05-06 | NERV | 0.00 | -0.55 | 0.51 |
| 2025-05-07 | NERV | 0.00 | -0.55 | 0.51 |
| 2025-05-08 | NERV | 0.00 | -0.55 | 0.51 |
| 2025-05-09 | NERV | 0.00 | -0.55 | 0.51 |
| 2025-05-12 | NERV | 0.00 | -0.54 | 0.50 |
| 2025-05-13 | NERV | 0.00 | -0.54 | 0.50 |
| 2025-05-14 | NERV | 0.00 | -0.54 | 0.50 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.56
Avg. EPS Est. Current Quarter
-1.07
Avg. EPS Est. Next Quarter
-0.9
Insider Transactions
Institutional Transactions
-0.54
Beta
-0.37
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
7
Growth Score
21
Sentiment Score
14
Actual DrawDown %
98.7
Max Drawdown 5-Year %
-98.9
Target Price
5
P/E
1.86
Forward P/E
PEG
P/S
P/B
P/Free Cash Flow
EPS
0.83
Average EPS Est. Cur. Y
-2.68
EPS Next Y. (Est.)
-1.88
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.28
Return on Equity vs Sector %
-29.3
Return on Equity vs Industry %
-12.4
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Minerva Neurosciences, IncSector: Healthcare
Industry: Biotechnology
Employees: 8
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of negative symptoms in patients with schizophrenia. The company also has exclusive rights to develop and commercialize MIN-301, a soluble recombinant form of the Neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
stock quote shares NERV – Minerva Neurosciences, Inc. Stock Price stock today
news today NERV – Minerva Neurosciences, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NERV – Minerva Neurosciences, Inc. yahoo finance google finance
stock history NERV – Minerva Neurosciences, Inc. invest stock market
stock prices NERV premarket after hours
ticker NERV fair value insiders trading